Pharmaceutical Investing

Kala Announces Enrollment Completion of Trial for Dry Eye Disease

Pharmaceutical Investing

Cardiol Therapeutics’ Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada

Cannabis Investing News

Neptune Reveals Acasti Share Sale After Failed Drug Study

Cannabis Investing News

Cannabidiol Offering a New Approach to Acute Myocarditis Treatment

SmartNews

Alexion Confirms Planned Phase 3 Study of ALS Treatment

Pharmaceutical Investing

Idera Pharmaceuticals Provides 2020 Update and Outlook

Pharmaceutical Investing

23andMe Working on New Drug Based on Users’ Genetics

Pharmaceutical Investing

Mereo and Oncologie Enter into Global Licensing Agreement

Pharmaceutical Investing

Avicanna Announces Agreement with Medical Cannabis by Shoppers, to Distribute Avicanna’s Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Products Across Canada

Cannabis Investing News

Marinus Provides Business Outlook for 2020

Pharmaceutical Investing

La Jolla Reports US$7.2 Million in Sales of GIAPREZA in Q4 2019

Pharmaceutical Investing

Kaleido Collaborates with Janssen on Metabolic Therapies

Pharmaceutical Investing

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES